New Product Launch Bioventus recently launched GELSYN-3, a three-injection hyaluronic acid product for knee osteoarthritis pain relief. This innovative product can be marketed to healthcare providers specializing in orthopedics and pain management.

Leadership Change With the appointment of Robert Claypoole as the new President and CEO, Bioventus is under new leadership. Sales teams can leverage this change to re-establish relationships and introduce the company's medical equipment solutions to new market segments.

Asset Sale Bioventus sold its Wound business to LifeNet Health for $85M, indicating a streamlined focus on core products. This presents an opportunity for sales professionals to explore partnerships with Bioventus for potential collaboration or distribution agreements.

Global Expansion Bioventus has international headquarters in The Netherlands and offices in multiple locations worldwide. This global presence can be leveraged by sales teams to introduce Bioventus' medical equipment solutions to new markets and forge partnerships with international healthcare providers.

Brand Reputation Despite legal issues, Bioventus remains a recognized global leader in orthobiologic solutions. Sales representatives can highlight the company's reputation for innovation and quality products to build trust with healthcare institutions and capitalize on Bioventus' brand strength to drive sales.